Reverse genetics for proteomics: From proteomic discovery to scientific content

Journal of Neural Transmission

Volumn 113, Issue 8, 2006, Pages 1033-1040

  Bauer, M ^a,b   Ueffing, M ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Parkinson's disease; Proteomics; Reverse genetics; RNAi; Transcriptomics; Ventral mesencephalon

Indexed keywords

BIOLOGICAL MONITORING; CELL FUNCTION; CYTOLOGY; DEGENERATIVE DISEASE; EXPERIMENTAL MODEL; FUNCTIONAL ASSESSMENT; GENETIC ANALYSIS; GENETIC MODEL; GENETICS; HUMAN; METHODOLOGY; MOLECULAR BIOLOGY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEOMICS; REVIEW; RNA INTERFERENCE; SCIENCE; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

ANIMALS; BRAIN CHEMISTRY; GENETICS; HUMANS; NEURODEGENERATIVE DISEASES; PROTEOMICS;

EID: 33746049440     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0516-4     Document Type: Review

References (33)

1. T Abbas-Terki W Blanco-Bose N Deglon W Pralong P Aebischer 2002 Lentiviral-mediated RNA interference Hum Gene Ther 13 2197 2201
2. M Basso S Giraudo D Corpillo B Bergamasco L Lopiano M Fasano 2004 Proteome analysis of human substantia nigra in Parkinson's disease Proteomics 4 3943 3952
3. M Bauer M Meyer J Sautter T Gasser M Ueffing HR Widmer 2001 Liposome-mediated gene transfer to fetal human ventral mesencephalic explant cultures Neurosci Lett 308 169 172
4. M Bauer S Suppmann M Meyer C Hesslinger T Gasser HR Widmer M Ueffing 2002 Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurons J Neurochem 82 1300 1310
5. TR Brummelkamp R Bernards R Agami 2002 A system for stable expression of short interfering RNAs in mammalian cells Science 296 550 553
6. CY Chung H Seo KC Sonntag A Brooks L Lin O Isacson 2005 Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection Hum Mol Genet 14 1709 1725
7. TM Dawson VL Dawson 2003 Molecular pathways of neurodegeneration in Parkinson's disease Science 302 819 822
8. WP Gilks PM Abou-Sleiman S Gandhi S Jain A Singleton AJ Lees K Shaw KP Bhatia V Bonifati NP Quinn J Lynch DG Healy JL Holton T Revesz NW Wood 2005 A common LRRK2 mutation in idiopathic Parkinson's disease Lancet 365 415 416
9. JT Greenamyre TG Hastings 2004 Biomedicine. Parkinson's - divergent causes, convergent mechanisms Science 304 1120 1122
10. GJ Hannon 2002 RNA interference Nature 418 244 251
11. SM Hauck S Suppmann M Ueffing 2003 Proteomic profiling of primary retinal Muller glia cells reveals a shift in expression patterns upon adaptation to in vitro conditions Glia 44 251 263
12. SM Hauck N Kinkl CA Deeg M Swiatek-de Lange S Schöffmann M Ueffing 2006 GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells Mol Cell Biol 26 2746 2757
13. DF Hudson C Morrison S Ruchaud WC Earnshaw 2002 Reverse genetics of essential genes in tissue-culture cells: 'dead cells talking' Trends Cell Biol 12 281 287
14. E Junn H Taniguchi BS Jeong X Zhao H Ichijo MM Mouradian 2005 Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death Proc Natl Acad Sci USA 102 9691 9696
15. C Lo Bianco BL Schneider M Bauer A Sajadi A Brice T Iwatsubo P Aebischer 2004 Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease Proc Natl Acad Sci USA 101 17510 17515
16. CB Lucking A Durr V Bonifati J Vaughan G De Michele T Gasser BS Harhangi G Meco P Denefle NW Wood Y Agid A Brice 2000 Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group N Engl J Med 342 1560 1567
17. AB Manning-Bog AL [tmp] McCormack MG Purisai LM Bolin DA Di Monte 2003 Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration J Neurosci 23 3095 3099
18. L Naldini U Blomer P Gallay D Ory R Mulligan FH Gage IM Verma D Trono 1996 In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 272 263 267
19. L Petrucelli C O'Farrell PJ Lockhart M Baptista K Kehoe L Vink P Choi B Wolozin M Farrer J Hardy MR Cookson 2002 Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons Neuron 36 1007 1019
20. MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer ES Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos WG Johnson AM Lazzarini RC Duvoisin G Di Iorio LI Golbe RL Nussbaum 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 2045 2047
21. H Sawada R Kohno T Kihara Y Izumi N Sakka M Ibi M Nakanishi T Nakamizo K Yamakawa H Shibasaki N Yamamoto A Akaike M Inden Y Kitamura T Taniguchi S Shimohama 2004 Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions J Biol Chem 279 10710 10719
22. TB Sherer R Betarbet AK Stout S Lund M Baptista AV Panov MR Cookson JT Greenamyre 2002 An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage J Neurosci 22 7006 7015
23. AB Singleton M Farrer J Johnson A Singleton S Hague J Kachergus M Hulihan T Peuralinna A Dutra R Nussbaum S Lincoln A Crawley M Hanson D Maraganore C Adler MR Cookson M Muenter M Baptista D Miller J Blancato J Hardy K Gwinn-Hardy 2003 alpha-Synuclein locus triplication causes Parkinson's disease Science 302 841
24. MG Spillantini ML Schmidt VM Lee JQ Trojanowski R Jakes M Goedert 1997 Alpha-synuclein in Lewy bodies Nature 388 839 840
25. L Studer M Csete SH Lee N Kabbani J Walikonis B Wold R [tmp] McKay 2000 Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen J Neurosci 20 7377 7383
26. H van der Putten KH Wiederhold A Probst S Barbieri C Mistl S Danner S Kauffmann K Hofele WP Spooren MA Ruegg S Lin P Caroni B Sommer M Tolnay G Bilbe 2000 Neuropathology in mice expressing human alpha-synuclein J Neurosci 20 6021 6029
27. M Vila S Przedborski 2004 Genetic clues to the pathogenesis of Parkinson's disease Nature Med 10 S58 S62
28. TT Warner AH Schapira 2003 Genetic and environmental factors in the cause of Parkinson's disease Ann Neurol 53 [Suppl 3] S16 S23
29. M Wiznerowicz D Trono 2003 Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference J Virol 77 8957 8961
30. T Yabe JT Herbert A Takanohashi JP Schwartz 2004 Treatment of cerebellar granule cell neurons with the neurotrophic factor pigment epithelium-derived factor in vitro enhances expression of other neurotrophic factors as well as cytokines and chemokines J Neurosci Res 77 642 652
31. A Zimprich S Biskup P Leitner P Lichtner M Farrer S Lincoln J Kachergus M Hulihan RJ Uitti DB Calne AJ Stoessl RF Pfeiffer N Patenge IC Carbajal P Vieregge F Asmus B Muller-Myhsok DW Dickson T Meitinger TM Strom ZK Wszolek T Gasser 2004 Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 601 607
32. R Zufferey D Nagy RJ Mandel L Naldini D Trono 1997 Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat Biotechnol 15 871 875
33. R Zufferey JE Donello D Trono TJ Hope 1999 Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors J Virol 73 2886 2892